Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-15

FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approves a supplemental application for mycophenolate mofetil from Hikma Pharmaceuticals USA Inc., reflecting a labeling update for this immunosuppressant u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

SUPPL AP for MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)